Letter: the effects of rifaximin in hepatic encephalopathy--authors' reply

Affiliations

¹ Gastrounit, Medical Division, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark; Department of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark. nina.kimer@regionh.dk.

Comment

N Kimer et al. Aliment Pharmacol Ther. 2014 Oct.

. 2014 Oct;40(7):858-9.

doi: 10.1111/apt.12904.

¹ Gastrounit, Medical Division, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark; Department of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark. nina.kimer@regionh.dk.

No abstract available

Comment on

Systematic review with meta-analysis: the effects of rifaximin in hepatic encephalopathy.
Kimer N, Krag A, Møller S, Bendtsen F, Gluud LL. Kimer N, et al. Aliment Pharmacol Ther. 2014 Jul;40(2):123-32. doi: 10.1111/apt.12803. Epub 2014 May 21. Aliment Pharmacol Ther. 2014. PMID: 24849268
Letter: the effects of rifaximin in hepatic encephalopathy.
Dai C, Jiang M, Sun MJ. Dai C, et al. Aliment Pharmacol Ther. 2014 Oct;40(7):857-8. doi: 10.1111/apt.12889. Aliment Pharmacol Ther. 2014. PMID: 25185736 No abstract available.